Carle F. Paul

Carle F. Paul

University Paul‐sabatier, Department Of Dermatology, Purpan University Hospital, Place Du Dr Baylac Toulouse, France

Direct Impact

Concepts for which Carle F Paul has direct influence:

atopic dermatitis
psoriatic arthritis
pimecrolimus cream
severe psoriasis
systemic mastocytosis
alcohol consumption
topical corticosteroids

External impact

Concepts related to the work of other authors for which Carle F Paul has influence:

atopic dermatitis
psoriatic arthritis
severe psoriasis
hand eczema
dabrafenib trametinib
peripheral edema
clobetasol propionate

Prominent publications by Carle F. Paul

KOL-Index: 139 Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and burden are best measured with a composite score, assessing both objective and subjective symptoms, such as SCORing Atopic Dermatitis (SCORAD). AD management must take into account clinical and pathogenic variabilities, the patient's age ...
KOL-Index: 112 For many decades and until recently, medical approach to dermatologic diseases has been based on the physician's ability to recognize and treat symptoms. Nowadays, advances in the understanding of the biology of diseases and in technologies for intervening against them have allowed physicians to diagnose and treat underlying disease processes rather than simply addressing the symptoms. This ...
KOL-Index: 68 BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease. There are no standardized methods for capturing long-term control of AD. OBJECTIVE: We sought to identify how long-term control has been captured in published randomized controlled trials (RCTs). Results will initiate consensus discussions on how best to measure long-term control in the core outcome set for AD. ...
Known for
Measure Recorded | Time Flare | Term Atopic | Points Published
KOL-Index: 57 OBJECTIVES: To review the pathophysiology, co-morbidities, and therapeutic options for psoriasis, psoriatic arthritis and rheumatoid arthritis in order to further understand the similarities and differences in treatment paradigms in the management of each disease. New targets for individualized therapeutic decisions are also identified with the aim of improving therapeutic outcome and ...
Known for
Arthritis Inflammation | Criteria Formal | Synthesis Articles | Identified Search
KOL-Index: 54 BACKGROUND: The incidence of skin cancers has been increasing steadily over the last decades. Although there have been significant breakthroughs in the management of skin cancers with the introduction of novel diagnostic tools and innovative therapies, skin cancer mortality, morbidity and costs heavily burden the society. OBJECTIVE: Members of the European Association of Dermato-Oncology, ...
Known for
Skin Cancer | Dermato-Oncology | Task Force | Cutaneous Lymphoma
KOL-Index: 48 OBJECTIVE: The aim of this study was to determine the prevalence of psoriatic arthritis (PsA) in the patients with plaque psoriasis and to give recommendation for the diagnosis of PsA for dermatologists. METHODS: A systematic search was performed in Pubmed, Cochrane and Embase databases. The key-words used from the Medical Searching Heading (MeSH) were: 'Psoriasis', 'Arthritis, Psoriatic', ...
Known for
Written French | Psa Plaque | Psoriasis Literature
KOL-Index: 44 BACKGROUND: Psoriatic arthritis (PsA) can develop at any time during the course of psoriasis. AIMS: The aims of these practical recommendations are to help dermatologists identify patients at risk of PsA, to diagnose PsA in collaboration with rheumatologists and to gain a better understanding of initial PsA management. MATERIALS AND METHODS: A scientific committee consisting of 10 ...
Known for
Questions Agreement | Psa Management | Varied Initial | Appraised
KOL-Index: 42 Drug-induced facial diseases are numerous. Clinical presentations can be various, from acneiform eruptions to photosensitivity. As a result, management is a challenge. This chapter presents the most frequent facial complications related to systemic or topical administration of drugs.
Known for
Frequent Facial Complications | Facial Drug
KOL-Index: 38 The lupus band test (LBT) is frequently performed for patients with lupus erythematosus (LE) but its capacity to discriminate cutaneous (C)LE from systemic (S)LE is debated, as well as its association with serum antinuclear antibodies (ANA) and complement reduction. Among 158 patients, 56 received retrospectively a diagnosis of CLE, 37 have SLE and 65 other skin disorders. Considering 29 ...
Known for
158 | Cle Systemic | Anti-Chromatin Response | Sle Skin

University Paul‐Sabatier, Department of Dermatology, Purpan University Hospital, Place du Dr Baylac Toulouse, France

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172